Myomectomy During CS: A Retrospective Cohort Study

NCT ID: NCT03270605

Last Updated: 2020-09-01

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

178 participants

Study Classification

OBSERVATIONAL

Study Start Date

2015-01-01

Study Completion Date

2019-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To evaluate the value of myomectomy during delivery by cesarean section (CS) in pregnant women with uterine fibroids.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cesarean Section Uterine Fibroid

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

CS with myomectomy

Women having uterine myoma with pregnancy and subjected to myomectomy during delivery by CS

Myomectomy

Intervention Type PROCEDURE

Surgical removal of uterine fibroid

CS without myomectomy

Women having uterine myoma with pregnancy and delivered by CS without myomectomy

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Myomectomy

Surgical removal of uterine fibroid

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Women who underwent elective CS with presence of uterine fibroid during the index pregnancy documented antenatal and at surgery

Exclusion Criteria

* Antepartum hemorrhage
* Blood diseases or bleeding tendencies.
* Medical conditions complicating pregnancy.
* Performed another surgical procedure at CS other than myomectomy.
Minimum Eligible Age

18 Years

Maximum Eligible Age

41 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Mansoura University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Waleed El-refaie, MD

Role: PRINCIPAL_INVESTIGATOR

Port Said University

Mohamed Hassan, MD

Role: STUDY_DIRECTOR

Mansoura University

Mohamed S Abdelhafez, MD

Role: STUDY_CHAIR

Mansoura University

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

R/17.04.71

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.